FHD-609 is an effective BRD9 inhibitor and PROTAC degrader, targeting the non-classical BAF (ncBAF) subunit BRD9, thereby depleting the SS18-SSX fusion protein, and can be used for the study of synovial sarcoma (SS).
Molecular Weight:
829
Purity:
99.96%
CAS Number:
[2676211-64-4]
Formula:
C47H56N8O6
Target:
Epigenetic Reader Domain|||PROTACs
T75135
* VAT and and shipping costs not included. Errors and price changes excepted